Flavouring and additive ingredients used in e-cigarettes are more likely to increase inflammation and impair lung function, according to new research. E-cigarettes -- popular battery-powered devices that simulate the act of smoking a traditional cigarette -- dispense a vapour derived from liquid chemicals in a refillable cartridge. Researchers from the University of Athens found that short-term exposure to e-cigarettes was enough to cause lung inflammation similar or worse than that seen in traditional cigarette use.
Each exposure session was separated by 30-minute smoke-free intervals.
One group was exposed to cigarette smoke, another with e-cigarette vapour containing propylene glycol and vegetable glycerol -- an odourless liquid derived from plant oils, the third with e-cigarette vapour containing propylene glycol and nicotine and another group was exposed to e-cigarette vapour containing propylene glycol, nicotine and tobacco flavouring.
In addition, two inflammation-producing proteins became elevated only in the flavouring group, which suggested that some flavouring components on the market may not be safe for even short-term use.
The level of oxidative stress -- stress at a cellular level -- in the flavouring group was equal to or higher than that of the cigarette group.
However, respiratory mechanics were adversely affected only in mice exposed to cigarette smoke and not to e-cigarette vapour after prolonged treatment.
"The observed detrimental effects in the lung upon (e-cigarette) vapour exposure in animal models highlight the need for further investigation of safety and toxicity of these rapidly expanding devices worldwide," the researchers warned.
No comments:
Post a Comment